Irbesartan treatment does not influence plasma levels of...

  • Main
  • 2020 / 09
  • Irbesartan treatment does not influence plasma levels of...
Diabetic Medicine 2020 / 09

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: an IRMA2 sub‐study

Piazza, M., Hanssen, N.M.J., Persson, F., Scheijen, J.L., van de Waarenburg, M.P.H., van Greevenbroek, M.M.J., Rossing, P., Hovind, P., Stehouwer, C.D.A., Parving, H‐H., Schalkwijk, C.G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Diabetic Medicine
DOI:
10.1111/dme.14405
Date:
September, 2020
File:
PDF, 763 KB
2020
Conversion to is in progress
Conversion to is failed